News Center

Home page

Peak Report

News reports

Remembering the Past

Release time:

2020-08-14

Memories of Past

■ Qiubin Pharmaceutical Factory Wang Haibin

Sun and Moon are like flies. It has been more than 10 20 years since it entered the peak. It was in the late 1990 s. With the deepening of reform and opening up and the restructuring of state-owned enterprises, many employees of state-owned enterprises, including me, were faced with life choices. At that time, there were many employment plans to choose from. I chose Jianfeng Group, because Jianfeng was the only listed company at the same level in Jinhua City at that time, and many young people dreamed of entering. Shortly after my resume was submitted, I successfully received the notice to go to work. At that time, I was very excited and felt that I had a platform to struggle and rely on.

Shortly after I went to work at the peak, I was assigned to the preparatory group of the Pharmaceutical Development Company to engage in the "Special New" disinfectant project transferred from Tianjin Medical Institute. In those years, due to the macro-control of national infrastructure projects and the depression of the cement industry, the group company made a strategic plan to enter the pharmaceutical industry. "Special New" was the first project of Jianfeng Pharmaceutical Development Company, and its significance can be imagined. We are all very excited to be the first batch of workers in the peak medical project, and we also feel the great burden and responsibility on our shoulders.

At that time, the personnel of the project team were basically transferred from outside, including Huang Fu Xiaosheng, a government cadre from Lanxi City, Zheng Yinghua, a process engineer, Wang Yulin, an equipment engineer, Huang Chaoyun and Yang Xiaojuan, chief engineers of the original dyeing and chemical plant, and Li Chengxiang, who graduated from Peking University. These new peak people from all over the world have a common wish, hoping that through the team and their own efforts, the project will be put into effect as soon as possible and contribute to the diversified development of the peak. Some of these former colleagues have retired, some have left the peak, and the memory of them has gradually blurred over time, but the past of those who worked together is still fresh in my mind. During the period of

, the colleagues of the project team worked hard according to the division of labor, day and night. Like everyone else, I do everything well. After careful study and calculation of the pilot scheme and design drawings submitted by Tianjin Medical Institute, according to the accumulation of previous work, the process flow chart with control points and the layout of equipment level and elevation are re-optimized and designed. The process equipment is arranged three-dimensionally according to the reaction steps and operation units. The plant space is reasonably utilized, and the equipment operation, maintenance and production control are more convenient and reliable.

The work during the trial production period is even more complicated. In addition to debugging the machine, we also need to organize raw and auxiliary materials, formulate process regulations, carry out staff training, prepare the trial production plan, etc. Everyone is very busy. The most worrying thing is that the project involves many flammable, explosive, toxic and hazardous chemicals such as toluene, chlorobenzene, n-hexane, ethanol, acetic acid, etc. At that time, the hydrogenation reduction and diazotization reactions in the production process have now been The national safety supervision department determines that it is a dangerous production process, and the requirements for fire and explosion prevention are particularly high. Most of our operators are transferred from cement plants and lack understanding of chemical production. Although they have conducted strict training and assessment before, they have no perceptual knowledge of hazardous chemicals, and they are often careless and random in their work. As a result, several small safety production accidents and attempted accidents occurred. In view of these situations, we have strengthened post inspection and hidden danger investigation, strengthened safety education, training and assessment, especially through strict implementation of hot work, inspection and maintenance and other work permit systems, and strengthened the inspection and assessment of "three violations" to prevent the occurrence of more accidents. Looking back on those days, it was precisely because we practiced the peak spirit of "unity and struggle, truth-seeking and innovation, determination to rise to the top, and forever climbing the peak" that we could complete the project design, equipment installation and trial production in less than half a year.

Although "Texin" was discontinued later due to market changes and improved management requirements, the pace of development of our peak pharmaceutical industry has not stopped. The product "Shu Jiaqing" of the Jiangnan Factory of Dier Pharmaceutical, a joint venture with Dier Pharmaceutical, is sold well in the north and south of the Yangtze River. The merger of Jinhua Biochemical Pharmaceutical Factory and the registration of Zhejiang Jianfeng Pharmaceutical Co., Ltd. have entered a healthy development track since then. With the cephalosporin powder injection preparation workshop, solid preparation workshop and Qiubin Pharmaceutical Factory of Jiangnan Factory of Jianfeng Pharmaceutical Co., Ltd. successively completed and put into operation, new products such as azithromycin, gatifloxacin, Lester, paroxetine and cefmenoxime were successively introduced, and Jinxi Factory, which is in line with international counterparts, was built in 2014 . The enterprise is growing day by day, the technology and equipment are becoming more and more advanced, and the efficiency is getting better and better. As a participant who has witnessed the development of Jianfeng Pharmaceutical from scratch, from small to large, and from weak to strong, I have witnessed the leaders and colleagues who have worked hard for this all the way, and also shared the achievements and joy brought by the development of the enterprise. I deeply realize that only when the enterprise develops can we realize our ideals; only when the employees of the enterprise work hard can the enterprise develop. The individual is a seed, the enterprise is the fertile land, the seed only buried in the fertile land, it is possible to thrive.

Past is like smoke, years are like songs. On the 33rd anniversary of peak start-up 60#, recalling these past events, I am deeply gratified that I decided to come to peak, and proud that I am a peak person! Dripping water en Yongquan newspaper, a mi en thousand dou also. Thanks to the peak for giving us such a platform for development, and thanks to the peak leadership team that led us all the way forward. As an old employee, I will try my best to stand on the last shift. I hope that the young scientific and technological workers of the peak will cherish the development platform provided by the enterprise, motivate themselves with the spirit of the peak, continue to innovate, and strive to create a beautiful century-old peak!

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页